Loading…
Solventum Corporation is projected to rise to $94.78 by 2027, a +24% move from its current price of $76.70. SOLV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $75.61 | $76.77 | $77.94 | +0.09% |
| Jul 15 | $75.20 | $76.83 | $78.50 | +0.17% |
| Jul 16 | $74.90 | $76.90 | $78.95 | +0.26% |
| Jul 17 | $74.66 | $76.97 | $79.34 | +0.35% |
| Jul 18 | $74.46 | $77.03 | $79.69 | +0.43% |
| Jul 19 | $74.29 | $77.10 | $80.02 | +0.52% |
| Jul 20 | $74.13 | $77.17 | $80.33 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $74.13 | $77.17 | $80.33 | +0.61% |
| Week 2 | $73.35 | $77.64 | $82.17 | +1.22% |
| Week 3 | $72.86 | $78.11 | $83.73 | +1.83% |
| Week 4 | $72.52 | $78.58 | $85.16 | +2.45% |
| Week 5 | $72.27 | $79.06 | $86.49 | +3.08% |
| Week 6 | $72.09 | $79.54 | $87.76 | +3.70% |
| Week 7 | $71.96 | $80.02 | $89.00 | +4.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Solventum Corporation is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.
site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Solventum Corporation (SOLV) is a healthcare company with a current price of $76.56 and a market cap of $13.26B, ranking 769. The stock trades in the healthcare sector and shows a bullish near-term and multi-year price outlook according to the forecast data.
A major floor 18.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.1% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 12.7% above — clearing it would confirm fresh momentum.
Key SOLV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SOLV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $76.41 | Buy | $76.51 | Buy |
| MA 10 | $77.36 | Sell | $76.78 | Sell |
| MA 20 | $76.81 | Sell | $76.86 | Sell |
| MA 50 | $75.63 | Buy | $75.58 | Buy |
| MA 100 | $72.05 | Buy | $74.50 | Buy |
| MA 200 | $74.62 | Buy | $74.05 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.17 | Neutral |
| Stoch RSI (14) | 46.55 | Neutral |
| CCI (20) | -5.13 | Neutral |
| Williams %R (14) | -47.40 | Info |
| MACD (12,26,9) | -0.27 | Sell |
| ROC (12) | 3.66 | Buy |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 52.60 | Neutral |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | -0.91 | Sell |
| Ultimate (7,14,28) | 49.26 | Neutral |
| Momentum (10) | -1.22 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 75.40 | Buy |
| ADX (14) | 12.36 | Neutral |
| ATR (14) | 1.17 | Info |
The 30-day technical picture is bullish in tone. The RSI (14) is 50, with the 50-day simple moving average at $72.88 and the 200-day simple moving average at $74.35. A near-term support is listed at $69.04 and a nearby resistance at $82.46, with the 30-day trading range between $68.25 and $85.88.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $62.49 | $76.70 | $107.11 | 0% | Neutral | |
| $77.63 | $94.78 | $120.99 | +24% | Bullish | |
| $99.29 | $123.51 | $161.93 | +61% | Bullish | |
| $116.95 | $147.72 | $197.80 | +93% | Bullish | |
| $121.41 | $155.43 | $211.86 | +103% | Bullish | |
| $132.92 | $172.23 | $238.48 | +125% | Bullish | |
| $140.09 | $183.59 | $257.82 | +139% | Bullish | |
| $150.70 | $199.57 | $283.90 | +160% | Bullish | |
| $175.84 | $235.17 | $338.54 | +207% | Bullish | |
| $198.46 | $267.94 | $390.00 | +249% | Bullish | |
| $263.07 | $370.44 | $565.05 | +383% | Bullish | |
| $551.83 | $833.39 | $1,362.65 | +987% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $62.49 | $76.70 | $92.54 | +0.00% |
| August 2026 | $69.99 | $81.93 | $97.97 | +6.82% |
| September 2026 | $70.57 | $83.00 | $100.03 | +1.31% |
| October 2026 | $70.42 | $83.16 | $100.88 | +0.19% |
| November 2026 | $72.25 | $85.62 | $104.44 | +2.96% |
| December 2026 | $73.48 | $87.36 | $107.11 | +2.04% |
Click any year to see its month-by-month SOLV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SOLV could reach as high as $107.11, with a base case around $76.70 and support toward $62.49 — roughly 0% from $76.70. A consolidation phase looks the most probable path here.
Expect SOLV to range from $77.63 to $120.99 through 2027. The $94.78 average target implies a +24% move from current prices. That is up +24% on the projected 2026 average. Momentum favours further upside here.
The SOLV price prediction for 2028 points to an average of $123.51 (low $99.29, high $161.93) — a potential gain of +61% on today's $76.70. Buyers look set to stay in control over this stretch.
In 2029, SOLV is projected to trade between $116.95 and $197.80, averaging $147.72 — a potential gain of +93% from today's $76.70. That is up +20% on the projected 2028 average. Momentum favours further upside here.
Solventum Corporation's 2030 outlook centres on $155.43, within a $121.41 to $211.86 range. That is up +5% on the projected 2029 average. That marks a +103% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, SOLV could reach as high as $238.48, with a base case around $172.23 and support toward $132.92 — roughly +125% from $76.70. Momentum favours further upside here.
Expect SOLV to range from $140.09 to $257.82 through 2032. The $183.59 average target implies a +139% move from current prices. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SOLV price prediction for 2033 points to an average of $199.57 (low $150.70, high $283.90) — a potential gain of +160% on today's $76.70. Momentum favours further upside here.
In 2034, SOLV is projected to trade between $175.84 and $338.54, averaging $235.17 — a potential gain of +207% from today's $76.70. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Solventum Corporation's 2035 outlook centres on $267.94, within a $198.46 to $390.00 range. That is up +14% on the projected 2034 average. That marks a +249% change versus current levels. Momentum favours further upside here.
By 2040, SOLV could reach as high as $565.05, with a base case around $370.44 and support toward $263.07 — roughly +383% from $76.70. Buyers look set to stay in control over this stretch.
Expect SOLV to range from $551.83 to $1,362.65 through 2050. The $833.39 average target implies a +987% move from current prices. That is up +125% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SOLV today (≈ 13.03781 SOLV) could be worth
$10,865.57
+$9,865.57 (+987%) by 2050 · US Dollar
Based on the average projected SOLV price of $833.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SOLVwould be worth at today's price.
$1,000 invested in SOLV on Jul 10, 2025 (≈ 13.178704 SOLV) would be worth
$1,010.81
+$10.81 (+1.1%) today · 1.01× · US Dollar
Based on a SOLV entry price of $75.88 vs. today's $76.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $78.27 | $979.94 | -2.0% |
| 1 month ago | $80.94 | $947.62 | -5.2% |
| 3 months ago | $65.79 | $1,165.83 | +16.6% |
| 6 months ago | $85.69 | $895.09 | -10.5% |
| 1 year ago | $75.88 | $1,010.81 | +1.1% |
| All time (2.3y) ago | $80 | $958.75 | -4.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SOLV forecast.
Our base-case forecast reaches $150.00 around 2030.
Implied market cap at $150.00: $25.98B
The multi-year forecast shows a clear path to higher prices. In 2026, the avg price is $76.56 with a min of $62.49 and a max of $105.25, yielding a neutral sentiment. By 2030, the avg price rises to $147.18 with a max of $200.85 and a min of $114.87, delivering a 92.3% ROI and a bullish outlook.
The forecast continues higher into 2040 with an avg of $343.20 and a 348.3% ROI, and reaches an avg of $722.29 in 2050 with an 843.4% ROI. The sentiment remains BULLISH across these years, illustrating meaningful upside potential while noting that these are estimates, not guarantees.
Tap a question to reveal the answer.
Avg $147.18, min $114.87, max $200.85; ROI 92.3%; sentiment BULLISH.
Forecasts show bullish sentiment and upside potential, with 2030 avg $147.18 and 2050 avg $722.29 plus a max of $1,181.47, but forecasts are estimates and not guarantees.
Yes. The forecast max for 2050 is $1,181.47, which exceeds $1,000.
Bullish sentiment with RSI 50; SMA50 $72.88; SMA200 $74.35; support $69.04; resistance $82.46; 30-day range $68.25 to $85.88.
Current price $76.56; market cap $13.26B.
Solventum Corporation Community Discussion
0Share your Solventum Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.